Page last updated: 2024-09-02

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and 5-carboxamidotryptamine

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with 5-carboxamidotryptamine in 1 studies

Compound Research Comparison

Studies
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Trials
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Recent Studies (post-2010)
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Studies
(5-carboxamidotryptamine)
Trials
(5-carboxamidotryptamine)
Recent Studies (post-2010) (5-carboxamidotryptamine)
13872392136

Protein Interaction Comparison

ProteinTaxonomyl-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50)5-carboxamidotryptamine (IC50)
5-hydroxytryptamine receptor 1DSus scrofa (pig)0.004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, J; Stephens, RL; Varanasi, S1

Other Studies

1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and 5-carboxamidotryptamine

ArticleYear
5-CT or DOI augments TRH analog-induced gastric acid secretion at the dorsal vagal complex.
    The American journal of physiology, 1997, Volume: 273, Issue:5

    Topics: Amphetamines; Animals; Drug Synergism; Gastric Acid; Gastric Mucosa; Male; Medulla Oblongata; Microinjections; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Thyrotropin-Releasing Hormone; Vagus Nerve

1997